Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: A multicenter, randomized, double-blind, placebo-controlled clinical trial

Annals of Emergency Medicine

Volumn 61, Issue 5, 2013, Pages 597-598

  Sud, Payal ^a   Nelson, Lewis ^b   Diller, David ^c  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DROPERIDOL; MIDAZOLAM; OLANZAPINE; PLACEBO; BENZODIAZEPINE DERIVATIVE; HYPNOTIC SEDATIVE AGENT;

AGITATION; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; HUMAN; LETTER; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); EMERGENCY HEALTH SERVICE; FEMALE; MALE; PSYCHOMOTOR AGITATION;

BENZODIAZEPINES; DROPERIDOL; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDAZOLAM; PSYCHOMOTOR AGITATION;

EID: 84876708692     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2012.10.043     Document Type: Letter

References (1)

1. E.W. Chan, D.M. Taylor, J.C. Knott Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial Ann Emerg Med 61 2012 72 81